Procyon Advisors LLC Sells 2,607 Shares of CME Group Inc. (NASDAQ:CME)

Procyon Advisors LLC lowered its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 12.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 17,952 shares of the financial services provider’s stock after selling 2,607 shares during the period. Procyon Advisors LLC’s holdings in CME Group were worth $4,169,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Truvestments Capital LLC bought a new position in shares of CME Group in the third quarter worth about $26,000. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares in the last quarter. Fortitude Family Office LLC boosted its stake in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares during the period. Thurston Springer Miller Herd & Titak Inc. grew its holdings in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares in the last quarter. Finally, Anchor Investment Management LLC grew its holdings in CME Group by 52.4% during the 3rd quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock valued at $83,000 after buying an additional 130 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CME has been the subject of a number of research reports. Barclays upped their target price on shares of CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research report on Monday, December 9th. Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Piper Sandler lifted their target price on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $229.27.

Read Our Latest Stock Report on CME Group

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This represents a 15.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,274 shares of company stock valued at $1,648,071 in the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.9 %

Shares of CME opened at $232.31 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $249.02. The company has a market cap of $83.72 billion, a PE ratio of 24.43, a P/E/G ratio of 4.93 and a beta of 0.56. The business has a fifty day moving average of $232.95 and a 200 day moving average of $219.42.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the company earned $2.25 EPS. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts expect that CME Group Inc. will post 10.2 EPS for the current year.

CME Group Increases Dividend

The firm also recently announced a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a dividend of $5.80 per share. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group announced that its board has approved a share buyback plan on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.